Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells-Reference-Cited by-同舟云学术

Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells

Published:2021-12 Issue: Volume:23 Page:241-253
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Lemmens Myriam,Fischer Benoit,Zogg Michael,Rodrigues Lindsey,Kerr Grainne,del Rio-Espinola Alberto,Schaeffer Fanny,Maddalo Danilo^ORCID,Dubost Valerie,Piaia Alessandro,Mueller Arne,Plappert-Helbig Ulla,Naumann Ulrike^ORCID,Haegele Jasmin,Odermatt Alex^ORCID,Martus Hans-Jörg,Libertini Silvana^ORCID

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference80 articles.

1. Genome editing technologies: defining a path to clinic;Corrigan-Curay;Mol. Ther.,2015

2. DNA targeting specificity of RNA-guided Cas9 nucleases;Hsu;Nat. Biotechnol.,2013

3. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells;Fu;Nat. Biotechnol.,2013

4. Unexpected genomic rearrangements at targeted loci associated with CRISPR/Cas9-mediated knock-in;Rezza;Sci. Rep.,2019

5. Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements;Kosicki;Nat. Biotechnol.,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article;Human Gene Therapy;2024-08-01

2. Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review;Frontiers in Oncology;2024-06-07

3. Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies;Mutation Research - Genetic Toxicology and Environmental Mutagenesis;2024-05

4. Kinase Suppressor of RAS 1 (KSR1) Maintains the Transformed Phenotype of BRAFV600E Mutant Human Melanoma Cells;International Journal of Molecular Sciences;2023-07-23

5. Assessing Tumorigenicity in Stem Cell-Derived Therapeutic Products: A Critical Step in Safeguarding Regenerative Medicine;Bioengineering;2023-07-19